Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
34.14
+1.66 (5.11%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $3.4 billion as of June 18, 2026. Its market cap has increased by 103.25% in one year.
Market Cap
3.40B
Enterprise Value
2.44B
1-Year Change
103.25%
Ranking
Category
Stock Price
$34.14
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $3.40B, an increase of 936.12%. That is a compound annual growth rate of 44.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.40B | 24.21% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 3.52B |
| Viking Therapeutics | 3.52B |
| Telix Pharmaceuticals | 3.39B |
| Relay Therapeutics | 3.39B |
| Parabilis Medicines | 3.31B |
| Arcutis Biotherapeutics | 3.28B |
| Structure Therapeutics | 3.20B |
| Dyne Therapeutics | 3.17B |